Skip to article
Astra

Neurocritical Care

Myasthenic Crisis Treatment Selection

Select plasma exchange or IVIG immediately for crisis or imminent respiratory and bulbar failure, while securing the airway, treating precipitants, and sequencing corticosteroids to avoid early worsening. Choice depends on physiologic urgency, access, contraindications, prior response, and complications.

Clinical question: How should clinicians select and sequence rescue immunotherapy, ventilatory support, and corticosteroids in myasthenic crisis?

First Decision

Separate impending crisis from manifest crisis before choosing rescue therapy

Treatment selection begins with airway risk and the capacity to rescue deterioration immediately.

Admit a patient with impending crisis to the hospital for close serial assessment of respiratory and bulbar function, with immediate capability to transfer to intensive care if deterioration occurs. Admit manifest crisis to an ICU or step-down unit able to manage respiratory failure and bulbar dysfunction. NeurologyInternational consensus guidance for management of myasthenia gravis

Define the immediate airway problem clinically: respiratory insufficiency requiring mechanical ventilation or intubation for airway protection constitutes myasthenic crisis. Do not defer intubation in progressive ventilatory failure, ineffective airway protection, or rapidly worsening bulbar weakness while waiting for immunotherapy to work. JAMAPredictors of Extubation Failure in Myasthenic CrisisWileyMyasthenic crisis

At presentation, actively identify and correct reversible precipitants while initiating rescue treatment. Crisis care priorities include airway, respiratory, and circulatory support; confirmation of MG and crisis; evaluation and treatment of acute respiratory failure; elimination of triggers; immunomodulatory treatment; and prevention or treatment of complications. WileyMyasthenic crisis

Level-of-care and rescue-treatment decisions in impending versus manifest myasthenic crisis. NeurologyInternational consensus guidance for management of myasthenia gravisNeurologyInternational consensus guidance for management of myasthenia ...
Clinical stateDispositionImmediate treatment selectionDecision trigger
Impending crisis with worsening respiratory or bulbar functionHospital admission with close observation and capacity for ICU transfer. NeurologyInternational consensus guidance for management of myasthenia gravisInitiate PLEX or IVIG when rapid improvement is needed or respiratory/bulbar dysfunction is significant. NeurologyInternational consensus guidance for management of myasthenia gravisProgression in respiratory or bulbar impairment warrants ICU-level management. NeurologyInternational consensus guidance for management of myasthenia gravis
Manifest crisis with respiratory failure or airway-protection indicationICU or capable step-down unit. NeurologyInternational consensus guidance for management of myasthenia gravisProvide airway and ventilatory support; initiate PLEX or IVIG as crisis rescue therapy. NeurologyInternational consensus guidance for management of myasthenia gravisNeurologyInternational consensus guidance for management of myasthenia ...Mechanical ventilation or intubation for airway protection defines the crisis state. JAMAPredictors of Extubation Failure in Myasthenic Crisis

Rescue Immunotherapy

Choose PLEX or IVIG according to urgency, feasibility, and patient-specific risk

Both modalities are accepted short-term therapies; selection should be deliberate rather than protocol automatic.

PLEX and IVIG are both appropriate short-term treatments for life-threatening respiratory insufficiency or dysphagia, significant bulbar dysfunction before surgery, need for rapid response, inadequate response to other treatments, and selected situations before corticosteroid initiation. NeurologyInternational consensus guidance for management of myasthenia gravis PLEX has strong guideline support and typically reaches maximal efficacy after three to five treatment sessions. BMJEfgartigimod following plasma exchange in the treatment of subjects ...

When physiologic urgency is extreme, PLEX is commonly favored if it can be delivered safely. Comparative literature describes PLEX as producing faster and more noticeable improvement in some studies, and a retrospective crisis cohort found PLEX superior to IVIG for 7-day severity, 2-week ventilation status, and 1-month functional outcome; these data are not definitive enough to establish universal superiority. WileyMyasthenic crisisWolters KluwerMyasthenic crisis : Muscle & Nerve - OvidNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection

Choose IVIG when the logistics, vascular access requirements, or hemodynamic demands of PLEX are unfavorable, or when IVIG is the more deliverable option. Randomized studies in MG exacerbation found IVIG as effective as PLEX at approximately 14 to 15 days, and an earlier trial found no difference in myasthenic muscle score at day 15 among PLEX and IVIG regimens. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsWileyMyasthenic crisis In COVID-19-associated crisis, IVIG may be preferable because PLEX removes circulating protective as well as pathogenic antibodies, although the clinical consequence of lowering antiviral antibody titers remains uncertain. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection

Do not interpret failure of one modality as a reason to abandon rescue therapy. If an exacerbation or crisis was not attributable to primary failure of the initial modality, retreatment may be reasonable; after exposure to both therapies, clinicians may retry the modality associated with the better prior response when there is a plausible benefit. nice org uk3 Committee discussion | Rozanolixizumab for treating antibody-positive generalised myasthenia gravis | Guidance | NICE

Practical selection between plasma exchange and IVIG for acute MG deterioration. BMJEfgartigimod following plasma exchange in the treatment of subjects ...NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsWileyMyasthenic crisisWolters KluwerMyasthenic crisis : Muscle & Nerve - OvidNeurologyInternational consensus guidance for management of myasthenia gravisNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
FactorPLEXIVIGHow it changes selection
Need for speed in severe crisisOften associated with faster and more noticeable improvement; peak effect is typically reached after three to five sessions. BMJEfgartigimod following plasma exchange in the treatment of subjects ...Wolters KluwerMyasthenic crisis : Muscle & Nerve - OvidEffective rescue therapy but may be selected less often when the fastest response is required. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infectionFavor PLEX when immediate reversal of severe weakness is the priority and delivery is feasible. Wolters KluwerMyasthenic crisis : Muscle & Nerve - OvidNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
Moderate-to-severe exacerbation efficacyComparable with IVIG in randomized exacerbation studies at about 14 to 15 days. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsComparable with PLEX in randomized exacerbation studies at about 14 to 15 days. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsEither is reasonable when urgency does not clearly favor PLEX. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
Respiratory or bulbar dysfunctionAppropriate short-term therapy. NeurologyInternational consensus guidance for management of myasthenia gravisAppropriate short-term therapy. NeurologyInternational consensus guidance for management of myasthenia gravisDo not delay either modality when dysfunction is clinically significant. NeurologyInternational consensus guidance for management of myasthenia gravis
COVID-19-associated crisisMay remove protective as well as pathogenic antibodies. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infectionOften more appropriate in this setting. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infectionFavor IVIG when this immunologic tradeoff is important. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
Preoperative optimizationThree treatments are recommended in one review. WileyMyasthenic crisis - Claytor - 2023 - Muscle & NerveMay be used in selected patients, although a trial did not show pre-thymectomy benefit for IVIG. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsConsider PLEX for significant preoperative weakness when rapid optimization is needed. WileyMyasthenic crisis - Claytor - 2023 - Muscle & Nerve

What the comparative evidence changes

The evidence supports a modality-selection approach rather than a claim that one rescue therapy always dominates. IVIG and PLEX are generally considered equally effective for moderate-to-severe generalized MG exacerbation with a similar duration of benefit, but PLEX may provide a faster or more pronounced response in severe crisis. NatureIntravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific ReportsWolters KluwerMyasthenic crisis : Muscle & Nerve - OvidNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection Therefore, use urgency, feasibility, prior response, and complication risk to break the tie.

Treatment Sequencing

Sequence corticosteroids after rescue therapy when early worsening could endanger the airway

Rescue immunotherapy provides short-lived benefit; sustained immunosuppression must be timed around its early risks.

Corticosteroids or other immunosuppressive agents are commonly started at the time of PLEX or IVIG to establish a sustained response. Because corticosteroids can transiently worsen myasthenic weakness, it may be safer to wait several days for PLEX or IVIG benefit before initiating corticosteroids when respiratory or bulbar reserve is limited. NeurologyInternational consensus guidance for management of myasthenia gravis

Corticosteroids remain an important component of crisis treatment in most patients, but they do not replace PLEX or IVIG for acute rescue because clinical response requires weeks and maximal benefit is delayed. Wolters KluwerNeuromuscular Disorders in the Intensive Care Unit - ContinuumNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection In a patient who is already unstable, use airway planning and rescue immunotherapy to bridge this delay rather than relying on steroid escalation alone. NeurologyInternational consensus guidance for management of myasthenia gravisNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection

Reassess pyridostigmine and other cholinesterase inhibitors during crisis. Excess cholinesterase inhibition is an uncommon but possible contributor to deterioration, and increased airway secretions can worsen respiratory management. NeurologyInternational consensus guidance for management of myasthenia gravis In the intubated patient with secretion burden, this tradeoff may favor withholding or reducing the agent until airway control and respiratory mechanics improve.

Sequencing immunotherapy and cholinesterase inhibition during crisis. Wolters KluwerNeuromuscular Disorders in the Intensive Care Unit - ContinuumNeurologyInternational consensus guidance for management of myasthenia gravisNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
InterventionRole in crisisTiming considerationKey tradeoff
PLEX or IVIGPrimary short-term rescue therapy for impending or manifest crisis. NeurologyInternational consensus guidance for management of myasthenia gravisNeurologyInternational consensus guidance for management of myasthenia ...Start promptly when respiratory or bulbar dysfunction is significant. NeurologyInternational consensus guidance for management of myasthenia gravisBenefits are temporary and require a plan for sustained disease control. NeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
CorticosteroidsBuild sustained immunosuppressive response in most patients. Wolters KluwerNeuromuscular Disorders in the Intensive Care Unit - ContinuumNeurologyInternational consensus guidance for management of myasthenia gravisMay begin with rescue therapy, but waiting several days after PLEX or IVIG is appropriate when transient worsening would be dangerous. NeurologyInternational consensus guidance for management of myasthenia gravisCan transiently exacerbate weakness and may worsen infection. NeurologyInternational consensus guidance for management of myasthenia gravisNeurologyClinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection
Cholinesterase inhibitorMay require reassessment during respiratory failure. NeurologyInternational consensus guidance for management of myasthenia gravisAdjust according to airway secretion burden and clinical trajectory. NeurologyInternational consensus guidance for management of myasthenia gravisIncreased airway secretions may exacerbate breathing difficulties. NeurologyInternational consensus guidance for management of myasthenia gravis

Respiratory Support

Use extubation readiness and pulmonary complications to guide ventilatory strategy

Successful rescue treatment does not eliminate the need for a cautious liberation plan.

Mechanical ventilation is indicated for neuromuscular respiratory failure or when intubation is required for airway protection. JAMAPredictors of Extubation Failure in Myasthenic Crisis Continue aggressive respiratory support while PLEX or IVIG takes effect; intubation itself should not be viewed as rescue-treatment failure because crisis is defined by the need for ventilatory support or airway protection. JAMAPredictors of Extubation Failure in Myasthenic CrisisNeurologyInternational consensus guidance for management of myasthenia gravis

Before extubation, integrate bedside respiratory performance with pulmonary complication status. In a study of myasthenic crisis, male sex, prior crisis, atelectasis, and intubation longer than 10 days were associated with extubation failure. Among patients evaluated for reintubation, lower pH, lower forced vital capacity at extubation, atelectasis, and post-extubation BiPAP use predicted reintubation. JAMAPredictors of Extubation Failure in Myasthenic Crisis

Treat atelectasis and other pulmonary complications before a marginal extubation attempt whenever possible. Noninvasive ventilation may help avoid reintubation in selected patients, but the association between post-extubation BiPAP use and reintubation identifies a high-risk group rather than proof that BiPAP causes failure. JAMAPredictors of Extubation Failure in Myasthenic CrisisWileyMyasthenic crisis - Claytor - 2023 - Muscle & Nerve

Factors associated with extubation failure or reintubation in myasthenic crisis. JAMAPredictors of Extubation Failure in Myasthenic Crisis
FindingAssociationBedside implication
AtelectasisAssociated with extubation failure and reintubation. JAMAPredictors of Extubation Failure in Myasthenic CrisisAddress pulmonary collapse before extubation and monitor closely afterward. JAMAPredictors of Extubation Failure in Myasthenic Crisis
Intubation longer than 10 daysAssociated with extubation failure. JAMAPredictors of Extubation Failure in Myasthenic CrisisPlan a higher-risk liberation strategy rather than a routine extubation trial. JAMAPredictors of Extubation Failure in Myasthenic Crisis
Lower pH at extubationPredicted reintubation in analyzed patients. JAMAPredictors of Extubation Failure in Myasthenic CrisisCorrect or explain acidemia before proceeding with extubation. JAMAPredictors of Extubation Failure in Myasthenic Crisis
Lower forced vital capacity at extubationPredicted reintubation. JAMAPredictors of Extubation Failure in Myasthenic CrisisUse low FVC as a warning against extubating on apparent limb-strength improvement alone. JAMAPredictors of Extubation Failure in Myasthenic Crisis
BiPAP after extubationAssociated with reintubation. JAMAPredictors of Extubation Failure in Myasthenic CrisisTreat post-extubation NIV requirement as a marker for intensified surveillance. JAMAPredictors of Extubation Failure in Myasthenic Crisis

Exceptions

Escalate early in immune checkpoint inhibitor-associated and refractory crisis

Etiology and prior rescue response can change the urgency and acceptable treatment sequence.

Immune checkpoint inhibitor-associated MG can progress rapidly irrespective of initial apparent severity. In a systematic review and single-center series, 14 of 38 patients initially treated with corticosteroids alone progressed to respiratory failure, including four initially presenting with ocular symptoms; 18 of 19 patients receiving IVIG or PLEX first line improved. BMJImmune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of Cancer Hospitalize these patients and use early IVIG or PLEX rather than waiting for steroid response when MG is suspected clinically. BMJImmune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of Cancer

For refractory crisis after standard PLEX or IVIG, do not substitute case-report evidence for established rescue pathways. Eculizumab has been reported in refractory crisis, including successful extubation after failed PLEX and high-dose prednisone, but the evidence base consists of a case report and 19 additional reported cases. ScienceDirectEmergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirect If considered, recognize the need for prompt meningococcal vaccination and antibiotic prophylaxis described in that report; this is an exceptional rescue decision rather than routine first-line care. ScienceDirectEmergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirect

After acute stabilization, transition to long-term MG management rather than repeating rescue therapy indefinitely. The broader treatment armamentarium includes corticosteroids, nonsteroidal immunosuppressive therapy, FcRn inhibitors, complement inhibitors, B-cell-directed therapy, and thymectomy; thymectomy is required for thymoma and can benefit AChR-antibody-positive generalized nonthymomatous MG. BMJEfgartigimod following plasma exchange in the treatment of subjects ...BMJMyasthenia gravis - Symptoms, diagnosis and treatment | BMJ Best Practice US

Treatment-selection exceptions that alter the usual crisis pathway. BMJMyasthenia gravis - Symptoms, diagnosis and treatment | BMJ Best Practice USBMJImmune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of CancerScienceDirectEmergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirect
ScenarioSelection changeEvidence-based rationale
Immune checkpoint inhibitor-associated MGHospitalize and use IVIG or PLEX early rather than corticosteroids alone. BMJImmune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of CancerRapid deterioration occurred despite initially mild presentations; first-line IVIG or PLEX was associated with improvement in 18 of 19 reported patients. BMJImmune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of Cancer
Refractory crisis after standard rescueConsider exceptional escalation such as eculizumab only with specialist-led risk assessment. ScienceDirectEmergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirectPublished crisis experience is limited to case-based literature; reported use included meningococcal vaccination and antibiotic prophylaxis. ScienceDirectEmergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirect
Thymoma-associated MG after stabilizationPlan thymectomy as definitive disease-directed treatment. BMJMyasthenia gravis - Symptoms, diagnosis and treatment | BMJ Best Practice USThymectomy is required when thymoma is present. BMJMyasthenia gravis - Symptoms, diagnosis and treatment | BMJ Best Practice US

References

  1. Efgartigimod following plasma exchange in the treatment of subjects ...neurologyopen.bmj.com · neurologyopen.bmj.com
  2. Myasthenia gravis - Symptoms, diagnosis and treatment | BMJ Best Practice USbestpractice.bmj.com · bestpractice.bmj.com
  3. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature | Journal for ImmunoTherapy of Cancerjitc.bmj.com · jitc.bmj.com
  4. Predictors of Extubation Failure in Myasthenic Crisisjamanetwork.com · jamanetwork.com
  5. Noninvasive Ventilation in Myasthenic Crisis - JAMA Networkjamanetwork.com · jamanetwork.com
  6. Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis | Scientific Reportswww.nature.com · www.nature.com
  7. Efgartigimod versus intravenous immunoglobulin in the treatment of patients with impending myasthenic crisis | Scientific Reportswww.nature.com · www.nature.com
  8. Neuromuscular Disorders in the Intensive Care Unit - Continuumjournals.lww.com · journals.lww.com
  9. Acute Neuromuscular Respiratory Failure | Continuumjournals.lww.com · journals.lww.com
  10. Risk factors of myasthenic crisis after thymectomy for thymoma ...academic.oup.com · academic.oup.com
  11. Myasthenic crisisonlinelibrary.wiley.com · onlinelibrary.wiley.com
  12. Thymectomy for non-thymomatous myasthenia gravisacademic.oup.com · academic.oup.com
  13. Myasthenic crisis: Guidelines for prevention and treatmentwww.sciencedirect.com · www.sciencedirect.com
  14. Emergent role of complement inhibitors in myasthenic crisis: Understanding why, when and how - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  15. Myasthenic crisis: Guidelines for prevention and treatment - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  16. Effect of Intravenous Immunoglobulin or Plasmapheresis in Myasthenic Crisis and Worsening Myasthenia Gravis Compared to Without Rescue Treatment - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  17. Myasthenic crisis - Claytor - 2023 - Muscle & Nerveonlinelibrary.wiley.com · onlinelibrary.wiley.com
  18. 1670: COMPARATIVE EFFICACY OF IVIG AND PLASMA... - Lippincottjournals.lww.com · journals.lww.com
  19. Myasthenic crisis : Muscle & Nerve - Ovidjournals.lww.com · journals.lww.com
  20. International consensus guidance for management of myasthenia graviswww.neurology.org · www.neurology.org
  21. 3 Committee discussion | Rozanolixizumab for treating antibody-positive generalised myasthenia gravis | Guidance | NICEwww.nice.org.uk · www.nice.org.uk
  22. International consensus guidance for management of myasthenia ...www.neurology.org · www.neurology.org
  23. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infectionwww.neurology.org · www.neurology.org
  24. Myasthenia graviswww.neurology.org · www.neurology.org